Home/ Shop/ Weight Management/ SEMAGLUTIDE 10mg

Weight Management

SEMAGLUTIDE 10mg

Semaglutide · 10MG

70,00 €

Dose

Quantity

70,00 €

1 - 2 vials

66,50 € (5% off)

3 - 4 vials

63,00 € (10% off)

5 - 9 vials

56,00 € (20% off)

10+ vials

≥99% purity by HPLC
Janoshik COA with every lot
Lot-traceable from synthesis
EU-synthesised

In stock · Lot NZM-W-0021 · ships in 3–5 working days (EU)

Available for research procurement. Supplied as a lyophilized research compound with lot-specific COA.

Specifications

Lot NumberNZM-W-0021

Purity99.4% (HPLC)

Verified byJanoshik

Synthesis Date2026-04-10

FormLyophilized powder

StorageBelow 16°C · sealed

Third Party Lab Tested

Every lot is independently HPLC-tested by Janoshik Analytical, Europe's reference laboratory for peptide purity assessment. The COA shipped with your order is theirs, not ours.

Storage & Handling

Lyophilized peptides should be stored below 16°C, protected from light and moisture, for up to 24 months. Once reconstituted, refrigerate and use within 30 days for protocol consistency.

FormLyophilized powder

StorageLyophilized: below 16°C for up to 24 months. Reconstituted: refrigerate, use within 30 days.

Reconstitution

Reconstitute with bacteriostatic water using the volumes below. Add solvent slowly along the inside wall of the vial. Swirl gently, never shake, until fully dissolved.

Lab-handling protocol BAC Water · 0.9% benzyl alcohol The reconstitution solvent referenced above. Add to order →

Researched Benefits

Weight Reduction up to 14.9% Mean body-weight reduction at 68 weeks (STEP-1 trial). Glycemic Control A1C ↓ 1.4–1.8% SUSTAIN program HbA1c reductions. Cardiovascular Markers MACE ↓ 26% SELECT trial cardiovascular outcome reduction.

Product details

Single-pathway GLP-1 research.

Semaglutide is a 31-amino-acid GLP-1 receptor agonist modified for albumin binding and extended activity in experimental models. Its single-receptor profile makes it a defined comparator for research involving dual-pathway Tirzepatide and triple-pathway Retatrutide. This 10 MG Semaglutide peptide is supplied as a lyophilized vial in the NZM-Labs peptide catalogue.

Each production lot receives independent HPLC purity analysis and mass-spectrometry identity testing, with lot-specific documentation available through the Science section. For laboratory research only.

Compound Specs

Research specification table for SEMAGLUTIDE 10mg
Compound	Semaglutide
Sequence length	31 amino acids
Molecular mass	4113.6 Da
Modeled half-life	~7 days (modeled)
Mechanism / research class	GLP-1R agonist
Example laboratory preparation	10 MG vial with 2 mL bacteriostatic water (0.9% benzyl alcohol)
Calculated concentration	5 mg per 1.0 mL
Supply format	Semaglutide · 10 MG lyophilized research vial
Storage, lyophilized	store below 16°C for up to 24 months
Storage, reconstituted	refrigerate and use within 30 days

Quality standards

Synthesised.
Verified.
Documented.

Wireframe rendering of a research peptide vial alongside molecular structure

Verified Purity

Every lot HPLC-tested by Janoshik Analytical. Independent verification, never in-house only. Current lot: 99.4% (HPLC).

Mass-Spec Confirmed

Identity confirmed by mass spectrometry. Theoretical mass matches measured within 0.5 Da tolerance.

Lyophilized & Sealed

Supplied as lyophilized powder in a sealed crimp-cap vial for laboratory handling and storage.

Lot-Traceable

From synthesis batch to your delivery, every step is logged. Search lot NZM-W-0021 for full traceability.

Evidence base

Backed by research.
Measured in results.

Each tag opens the cited literature behind that effect. References are linked to PubMed.

up to 14.9%

Weight Reduction

Semaglutide is the deepest-cited single-pathway GLP-1 receptor agonist in metabolic research. The reference STEP-1 trial reported −14.9% mean body-weight reduction at 68 weeks in the published reference study arm - the baseline for any GLP-1 / GIP / GCG comparison.

References

Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. NEJM. 2021;384(11):989-1002. PubMed ↗

A1C ↓ 1.4–1.8%

Glycemic Control

GLP-1 receptor agonism amplifies glucose-dependent insulin secretion. Across the SUSTAIN trial program, Semaglutide produced A1C reductions of 1.4–1.8% in T2D research populations.

References

Sorli C et al. Efficacy and safety of once-weekly semaglutide. Lancet Diabetes Endocrinol. 2017;5(4):251-260. PubMed ↗

MACE ↓ 26%

Cardiovascular Markers

The SELECT cardiovascular outcomes trial reported a 26% relative reduction in major adverse cardiovascular events (MACE) on Semaglutide vs placebo in T2D populations with established CVD over 39.8 months.

References

Lincoff AM et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. NEJM. 2023;389(24):2221-2232. PubMed ↗

Specific to SEMAGLUTIDE 10mg

Questions?
We have answers.

(01)

GLP-1 vs GLP-1/GIP - when to use which?

Single-pathway GLP-1 (Semaglutide) is the established reference for metabolic research. Dual (Tirzepatide) and triple (Retatrutide) agonists expand the receptor profile and produce distinct downstream effects worth comparing in protocol design - but only if your hypothesis warrants it.

(02)

How is the Certificate of Analysis verified?

Every lot is sent to Janoshik Analytical for independent HPLC and mass spectrometry testing. The COA you receive is theirs, not ours - searchable by lot number on our Science page, no account required.

(03)

How is the product shipped?

Lyophilized vials are shipped across the EU. Store sealed vials below 16°C after delivery. Typical delivery takes 3–5 working days.

(04)

Is this a research product?

Yes. NZM peptides are sold strictly for in vitro and animal research use only. They are not for human consumption, off-label use, or clinical application. Please consult applicable local regulations before ordering.

(05)

What is the Semaglutide research peptide price?

The current Semaglutide price is shown on this page. Pricing applies to B2B research procurement only and may vary by lot, format, and availability.

(06)

Can research customers buy Semaglutide from NZM-Labs?

Yes. Research customers can order Semaglutide through NZM-Labs for in vitro and animal research use only. It is not sold for human consumption, clinical use, or self-administration.

Researcher reviews